Literature DB >> 6190070

Production and properties of monoclonal antibodies to guinea pig Ia antigens.

S E Zweig, E M Shevach.   

Abstract

Although the use of monoclonal antibodies to characterize the Ia antigen system is still in its infancy, the usefulness of this approach is clearly apparent. Since xenogeneic immunization can be used to generate these antibodies, the chances are good that a greater variety of Ia types and determinants will be detected compared to those detected with conventional alloantisera. In addition, the advantages of unlimited quantity and constant specificity allow a much greater degree of standardization than was previously possible. Finally, monoclonal antibodies open up lines of investigation, such as the examination of correlations between the monoclonal antibody's inhibition of T-cell proliferation and the antibody's corresponding Ia epitope-binding characteristics, that it would be impossible to approach using conventional alloantisera.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6190070     DOI: 10.1016/0076-6879(83)92010-4

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  5 in total

1.  Murine antiidiotypic monoclonal antibodies that bear the internal image of HLA-DR allospecificities.

Authors:  F Perosa; S Ferrone
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

2.  Active specific immunotherapy in patients with melanoma. A clinical trial with mouse antiidiotypic monoclonal antibodies elicited with syngeneic anti-high-molecular-weight-melanoma-associated antigen monoclonal antibodies.

Authors:  A Mittelman; Z J Chen; T Kageshita; H Yang; M Yamada; P Baskind; N Goldberg; C Puccio; T Ahmed; Z Arlin
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

3.  Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA.

Authors:  Z Wang; Y Cao; A P Albino; R A Zeff; A Houghton; S Ferrone
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

4.  Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.

Authors:  C M D'Urso; Z G Wang; Y Cao; R Tatake; R A Zeff; S Ferrone
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

5.  Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma.

Authors:  M Altomonte; R Montagner; E Fonsatti; F Colizzi; I Cattarossi; L I Brasoveanu; M R Nicotra; A Cattelan; P G Natali; M Maio
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.